Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma

被引:6
作者
Schmeusser, Benjamin N. [1 ]
Ali, Adil A. [1 ]
Fintelmann, Florian J. [2 ]
Garcia, Jose M. [3 ,4 ]
Williams, Grant R. [5 ,6 ]
Master, Viraj A. [1 ,7 ]
Psutka, Sarah P. [8 ,9 ]
机构
[1] Emory Univ, Dept Urol, Sch Med, 1365 Clifton Rd NE,Bldg B,Suite 1400, Atlanta, GA 30322 USA
[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA
[3] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA USA
[4] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Sch Med, Seattle, WA 98195 USA
[5] Univ Alabama, Inst Canc Outcomes & Survivorship, Alabama, NY USA
[6] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[8] Univ Washington, Dept Urol, 1959 NE Pacific Stree,Box 356510, Seattle, WA 98195 USA
[9] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA
关键词
Sarcopenia; Inflammation; Body composition; Skeletal muscle; Renal cell carcinoma (RCC); Prognostic factor; GLASGOW PROGNOSTIC SCORE; COMPUTED-TOMOGRAPHY IMAGES; SKELETAL-MUSCLE DEPLETION; DOSE-LIMITING TOXICITY; BODY-MASS INDEX; RADICAL NEPHRECTOMY; CANCER CACHEXIA; SOLID TUMORS; SURVIVAL; OBESITY;
D O I
10.1007/s11934-023-01157-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewThe purpose of this review is to provide an up-to-date understanding regarding the literature on sarcopenia and inflammation as prognostic factors in the context of renal cell carcinoma (RCC).Recent FindingsSarcopenia is increasingly recognized as a prognostic factor in RCC. Emerging literature suggests monitoring quantity of muscle on successive imaging and examining muscle density may be additionally informative. Inflammation has prognostic ability in RCC and is also considered a key contributor to development and progression of both RCC and sarcopenia. Recent studies suggest these two prognostic factors together may provide additional prognostic ability when used in combination. Ongoing developments include quality control regarding sarcopenia research and imaging, improving understanding of muscle loss mechanisms, and enhancing clinical incorporation of sarcopenia via improving imaging analysis practicality (i.e., artificial intelligence) and feasible biomarkers.Sarcopenia and systemic inflammation are complementary prognostic factors for adverse outcomes in patients with RCC. Further study on high-quality sarcopenia assessment standardization and expedited sarcopenia assessment is desired for eventual routine clinical incorporation of these prognostic factors.
引用
收藏
页码:317 / 334
页数:18
相关论文
共 155 条
[1]   Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective [J].
Abou Elkassem, Asser M. ;
Lo, Simon S. ;
Gunn, Andrew J. ;
Shuch, Brian M. ;
Dewitt-Foy, Molly E. ;
Abouassaly, Robert ;
Vaidya, Sandeep S. ;
Clark, Joseph, I ;
Louie, Alexander, V ;
Siva, Shankar ;
Grosu, Anca-Ligia ;
Smith, Andrew D. .
RADIOGRAPHICS, 2021, 41 (05) :1387-1407
[2]   Imaging of sarcopenia: old evidence and new insights [J].
Albano, Domenico ;
Messina, Carmelo ;
Vitale, Jacopo ;
Sconfienza, Luca Maria .
EUROPEAN RADIOLOGY, 2020, 30 (04) :2199-2208
[3]   Myosteatosis and prognosis in cancer: Systematic review and meta-analysis [J].
Aleixo, G. F. P. ;
Shachar, S. S. ;
Nyrop, K. A. ;
Muss, H. B. ;
Malpica, Luis ;
Williams, G. R. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
[4]  
Anjanappa Milan, 2020, Tech Innov Patient Support Radiat Oncol, V16, P50, DOI 10.1016/j.tipsro.2020.10.001
[5]   Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma [J].
Antoun, S. ;
Baracos, V. E. ;
Birdsell, L. ;
Escudier, B. ;
Sawyer, M. B. .
ANNALS OF ONCOLOGY, 2010, 21 (08) :1594-1598
[6]   Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies [J].
Antoun, Sami ;
Lanoy, Emilie ;
Iacovelli, Roberto ;
Albiges-Sauvin, Laurence ;
Loriot, Yohann ;
Merad-Taoufik, Mansouriah ;
Fizazi, Karim ;
di Palma, Mario ;
Baracos, Vickie E. ;
Escudier, Bernard .
CANCER, 2013, 119 (18) :3377-3384
[7]   Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma [J].
Aslan, Volkan ;
Kilic, Atiye Cenay Karabork ;
Sutcuoglu, Osman ;
Eraslan, Emrah ;
Bayrak, Ahmet ;
Oksuzoglu, Berna ;
Tahtaci, Gozde ;
Ozdemir, Nuriye ;
Uner, Aytug ;
Gunel, Nazan ;
Ozet, Ahmet ;
Yazici, Ozan .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) :494.e1-494.e10
[8]   Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma [J].
Auclin, Edouard ;
Bourillon, Camille ;
De Maio, Eleonora ;
By, Marie Agnes ;
Seddik, Sofiane ;
Fournier, Laure ;
Auvray, Marie ;
Dautruche, Antoine ;
Vano, Yann-Alexandre ;
Thibault, Constance ;
Joly, Florence ;
Brunereau, Laurent ;
Gomez-Roca, Carlos ;
Chevreau, Christine ;
Elaidi, Reza ;
Oudard, Stephane .
CLINICAL GENITOURINARY CANCER, 2017, 15 (03) :350-355
[9]   Clinically Practical Approach for Screening of Low Muscularity Using Electronic Linear Measures on Computed Tomography Images in Critically Ill Patients [J].
Avrutin, Egor ;
Moisey, Lesley L. ;
Zhang, Roselyn ;
Khattab, Jenna ;
Todd, Emma ;
Premji, Tahira ;
Kozar, Rosemary ;
Heyland, Daren K. ;
Mourtzakis, Marina .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2018, 42 (05) :885-891
[10]   Inflammation and sarcopenia: A systematic review and meta-analysis [J].
Bano, Giulia ;
Trevisan, Caterina ;
Carraro, Sara ;
Solmi, Marco ;
Luchini, Claudio ;
Stubbs, Brendon ;
Manzato, Enzo ;
Sergi, Giuseppe ;
Veronese, Nicola .
MATURITAS, 2017, 96 :10-15